These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 34293421)

  • 1. Does NAFLD mediate the relationship between obesity and type 2 diabetes risk? evidence from the multi-ethnic study of atherosclerosis (MESA).
    Rodriguez LA; Kanaya AM; Shiboski SC; Fernandez A; Herrington D; Ding J; Bradshaw PT
    Ann Epidemiol; 2021 Nov; 63():15-21. PubMed ID: 34293421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus.
    Li WD; Fu KF; Li GM; Lian YS; Ren AM; Chen YJ; Xia JR
    World J Gastroenterol; 2015 Aug; 21(32):9607-13. PubMed ID: 26327768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender-specific association between non-alcoholic fatty liver disease and type 2 diabetes mellitus among a middle-aged and elderly Chinese population: An observational study.
    Ni L; Yu D; Wu T; Jin F
    Medicine (Baltimore); 2021 Feb; 100(6):e24743. PubMed ID: 33578624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting Non-Alcoholic Fatty Liver Disease for Adults Using Practical Clinical Measures: Evidence from the Multi-ethnic Study of Atherosclerosis.
    Rodriguez LA; Shiboski SC; Bradshaw PT; Fernandez A; Herrington D; Ding J; Bradley RD; Kanaya AM
    J Gen Intern Med; 2021 Sep; 36(9):2648-2655. PubMed ID: 33501527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effect of non-alcoholic fatty liver disease and history of gestational diabetes to increase risk of type 2 diabetes.
    Cho Y; Chang Y; Ryu S; Wild SH; Byrne CD
    Eur J Epidemiol; 2023 Aug; 38(8):901-911. PubMed ID: 37253998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between the lean nonalcoholic fatty liver disease and risk of incident type 2 diabetes in a healthy population of Northwest China: a retrospective cohort study with a 2-year follow-up period.
    Li N; Xang W; Wu S; Li D; Chang M; Xie C; Zhang MY; Tan H
    Front Endocrinol (Lausanne); 2023; 14():1173757. PubMed ID: 37435491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH.
    Ampuero J; Aller R; Gallego-Durán R; Crespo J; Calleja JL; García-Monzón C; Gómez-Camarero J; Caballería J; Lo Iacono O; Ibañez L; García-Samaniego J; Albillos A; Francés R; Fernández-Rodríguez C; Diago M; Soriano G; Andrade RJ; Latorre R; Jorquera F; Morillas RM; Escudero D; Estévez P; Guerra MH; Augustín S; Banales JM; Aspichueta P; Benlloch S; Rosales JM; Salmerón J; Turnes J; Romero Gómez M;
    J Hepatol; 2020 Jul; 73(1):17-25. PubMed ID: 32147361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-dependent effects of diabetes and obesity on liver-related events in non-alcoholic fatty liver disease: Subanalysis of CLIONE in Asia.
    Seko Y; Kawanaka M; Fujii H; Iwaki M; Hayashi H; Toyoda H; Oeda S; Hyogo H; Morishita A; Munekage K; Kawata K; Yamamura S; Sawada K; Maeshiro T; Tobita H; Yoshida Y; Naito M; Araki A; Arakaki S; Kawaguchi T; Noritake H; Ono M; Masaki T; Yasuda S; Tomita E; Yoneda M; Tokushige A; Kamada Y; Takahashi H; Ueda S; Aishima S; Sumida Y; Okanoue T; Itoh Y; Nakajima A;
    J Gastroenterol Hepatol; 2022 Dec; 37(12):2313-2320. PubMed ID: 36198983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Non-alcoholic fatty liver disease increases the incidence rate of type 2 diabetes mellitus: a cohort study based on a rural town elderly population of southern Jiangsu].
    Shao Y; Xu JY; Lu XL; Chen J; Li T; Wang YT; Shi HT
    Zhonghua Gan Zang Bing Za Zhi; 2021 Sep; 29(9):867-872. PubMed ID: 34638206
    [No Abstract]   [Full Text] [Related]  

  • 10. Association of non-alcoholic fatty liver disease with total testosterone in non-overweight/obese men with type 2 diabetes mellitus.
    Yang LJ; Zhou JZ; Zheng YF; Hu X; He ZY; Du LJ; Gu X; Huang XY; Li J; Li YQ; Pan LY; Zhang XX; Gu XJ
    J Endocrinol Invest; 2023 Aug; 46(8):1565-1572. PubMed ID: 36725809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of nonalcoholic fatty liver disease and liver cirrhosis in Chinese adults with type 2 diabetes mellitus.
    Han X; Zhang X; Liu Z; Fan H; Guo C; Wang H; Gu Y; Zhang T
    J Diabetes; 2024 May; 16(5):e13564. PubMed ID: 38664879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired fasting glucose and the risk of incident diabetes mellitus and cardiovascular events in an adult population: MESA (Multi-Ethnic Study of Atherosclerosis).
    Yeboah J; Bertoni AG; Herrington DM; Post WS; Burke GL
    J Am Coll Cardiol; 2011 Jul; 58(2):140-6. PubMed ID: 21718910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonalcoholic fatty liver disease and type 2 diabetes: an observational and Mendelian randomization study.
    Yu Y; Yu Y; Wang Y; Chen Y; Wang N; Wang B; Lu Y
    Front Endocrinol (Lausanne); 2023; 14():1156381. PubMed ID: 37223039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Relationship Between Glycaemic Control and Non-Alcoholic Fatty Liver Disease in Nigerian Type 2 Diabetic Patients.
    Afolabi BI; Ibitoye BO; Ikem RT; Omisore AD; Idowu BM; Soyoye DO
    J Natl Med Assoc; 2018 Jun; 110(3):256-264. PubMed ID: 29778128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examining if the relationship between BMI and incident type 2 diabetes among middle-older aged adults varies by race/ethnicity: evidence from the Multi-Ethnic Study of Atherosclerosis (MESA).
    Rodriguez LA; Bradshaw PT; Shiboski SC; Fernandez A; Vittinghoff E; Herrington D; Ding J; Kanaya AM
    Diabet Med; 2021 May; 38(5):e14377. PubMed ID: 32750175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-alcoholic fatty liver disease predicts type 2 diabetes mellitus, but not prediabetes, in Xi'an, China: a five-year cohort study.
    Ming J; Xu S; Gao B; Liu G; Ji Y; Yang F; Jia Y; Fang Y; Ji Q
    Liver Int; 2015 Nov; 35(11):2401-7. PubMed ID: 25879672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-obese or lean non-alcoholic fatty liver disease was associated with increased risk of cancer in patients with type 2 diabetes mellitus.
    Chen N; Zhou J; Wang K; Li X; Li Z
    BMJ Open Diabetes Res Care; 2023 Feb; 11(1):. PubMed ID: 36792168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-alcoholic fatty liver disease is associated with an increased risk of type 2 diabetes.
    Loosen SH; Krieg S; Krieg A; Qvartskhava N; Luedde T; Kostev K; Roderburg C
    Eur J Gastroenterol Hepatol; 2023 Jun; 35(6):662-667. PubMed ID: 37115964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal Associations Between Neighborhood Physical and Social Environments and Incident Type 2 Diabetes Mellitus: The Multi-Ethnic Study of Atherosclerosis (MESA).
    Christine PJ; Auchincloss AH; Bertoni AG; Carnethon MR; Sánchez BN; Moore K; Adar SD; Horwich TB; Watson KE; Diez Roux AV
    JAMA Intern Med; 2015 Aug; 175(8):1311-20. PubMed ID: 26121402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Independent Association Between Improvement of Nonalcoholic Fatty Liver Disease and Reduced Incidence of Type 2 Diabetes.
    Yamazaki H; Tsuboya T; Tsuji K; Dohke M; Maguchi H
    Diabetes Care; 2015 Sep; 38(9):1673-9. PubMed ID: 26156527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.